Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice P Dutcher

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 13, 2024
Families with multiple individuals with acute leukemia in their pedigreesPeter H Wiernik, Matthew P Blakley, Janice P Dutcher
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 4, 2020
On the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment-Cytokines, Targeted Therapy, and ImmunotherapyJanice P Dutcher, Ronan Flippot, Jaleh Fallah, et al.
Familial Cancer|June 24, 2016
Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in familiesJanice P Dutcher, Peter H Wiernik, Leticia Varella, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Novel management of pruritus in patients treated with IL-2 for metastatic renal cell carcinoma and malignant melanomaSung Ho Lee, Mahadi Baig, Valerie Rusciano, et al.
The Prostate|May 7, 2004
Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cellsThambi Dorai, Janice P Dutcher, David W Dempster, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2005
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanomaDoru T Alexandrescu, Prasad Maddukuri, Peter H Wiernik, et al.
Leukemia & Lymphoma|May 13, 2006
Mitoxantrone, vinblastine and CCNU: long-term follow-up of patients treated for advanced and poor-prognosis Hodgkin's diseaseDoru T Alexandrescu, Sirisha Karri, Peter H Wiernik, et al.
Journal of Investigative Medicine High Impact Case Reports|February 17, 2017
Long-Term Response and Possible Cure of Patients With B-Cell Malignancies With Dose-Escalated RituximabLauren M Jacobs, Peter H Wiernik, Janice P Dutcher, et al.
Cancer Investigation|December 13, 2006
Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesisThambi Dorai, Ihor Sawczuk, Jaromir Pastorek, et al.
Current Treatment Options in Oncology|April 18, 2006
Blastic phase of chronic myelogenous leukemiaMerat Karbasian Esfahani, Evelyn L Morris, Janice P Dutcher, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 13, 2024
Families with multiple individuals with acute leukemia in their pedigreesPeter H Wiernik, Matthew P Blakley, Janice P Dutcher
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 4, 2020
On the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment-Cytokines, Targeted Therapy, and ImmunotherapyJanice P Dutcher, Ronan Flippot, Jaleh Fallah, et al.
Familial Cancer|June 24, 2016
Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in familiesJanice P Dutcher, Peter H Wiernik, Leticia Varella, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Novel management of pruritus in patients treated with IL-2 for metastatic renal cell carcinoma and malignant melanomaSung Ho Lee, Mahadi Baig, Valerie Rusciano, et al.
The Prostate|May 7, 2004
Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cellsThambi Dorai, Janice P Dutcher, David W Dempster, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2005
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanomaDoru T Alexandrescu, Prasad Maddukuri, Peter H Wiernik, et al.
Leukemia & Lymphoma|May 13, 2006
Mitoxantrone, vinblastine and CCNU: long-term follow-up of patients treated for advanced and poor-prognosis Hodgkin's diseaseDoru T Alexandrescu, Sirisha Karri, Peter H Wiernik, et al.
Journal of Investigative Medicine High Impact Case Reports|February 17, 2017
Long-Term Response and Possible Cure of Patients With B-Cell Malignancies With Dose-Escalated RituximabLauren M Jacobs, Peter H Wiernik, Janice P Dutcher, et al.
Cancer Investigation|December 13, 2006
Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesisThambi Dorai, Ihor Sawczuk, Jaromir Pastorek, et al.
Current Treatment Options in Oncology|April 18, 2006
Blastic phase of chronic myelogenous leukemiaMerat Karbasian Esfahani, Evelyn L Morris, Janice P Dutcher, et al.
Pageof 9